Medicine & Life Sciences
gastric inhibitory polypeptide receptor
100%
Neurodegenerative Diseases
51%
Peptides
15%
Glucose
15%
Cerebrovascular Disorders
12%
Parkinson Disease
10%
Alzheimer Disease
9%
Incretins
7%
Endocrine System
7%
Glucagon-Like Peptide 1
7%
Neurogenesis
6%
Neuroprotection
6%
Expert Testimony
6%
Islets of Langerhans
5%
Traumatic Brain Injury
5%
Neuronal Plasticity
5%
Brain Diseases
5%
Synaptic Transmission
5%
Regeneration
5%
Nervous System
4%
Central Nervous System
4%
Hormones
4%
Therapeutics
3%
Neurons
3%
Growth
3%
Chemical Compounds
Insulinotropic
99%
Disorder
51%
Polypeptide
49%
Agent Interacting With Transmitter, Hormone or Drug Receptor
33%
Glucagon-Like Peptide 1
15%
Plastic Property
11%
Modification
11%
Hormone
9%
Application
3%